SYNTHEIN
Live / Allowed — Third extension granted (statement of use) (as of 13 May 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 31 Oct 2023 filing date already counts against anyone who files later.
Record
- Serial number
- 98248504
- Mark type
- Word mark
- Filed
- 31 Oct 2023
- Published for opposition
- 15 Oct 2024
- Attorney of record
- Christina Licursi
Goods and services
- Class 001 — Chemicals: Proteins for use in manufacture; synthetic proteins and synthetic peptides, in raw material form, for scientific and medical research; synthetic proteins and synthetic peptides for medical diagnostic purposes; synthetic proteins and synthetic peptides for treating viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; biomedical compounds, namely, peptide substrates used in analyzing and detecting certain toxins for clinical or medical laboratory use
- Class 040 — Treatment of materials: Custom manufacturing of genetically engineered proteins and peptides; custom manufacturing of engineered proteins and peptides; custom manufacturing and custom synthesis of engineered proteins and peptides for scientific, engineering, research, and medical use
- Class 042 — Scientific and technological services: Pharmaceutical, medical, scientific, and biopharmaceutical research and development; research and development of new products in the fields of proteins and peptides; scientific and medical research in the field of proteins and peptides; scientific and engineering research services relating to synthetic biology, genetic engineering, biotechnology and biological engineering; computer-aided design of genetically engineered proteins and peptides; computer-aided design of engineered proteins and peptides
Owner
- Abiologics, Inc., Cambridge, MA, US
- Abiologics, Inc., Cambridge, MA, US
Prosecution history
- 14 May 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 13 May 2026 — SOU EXTENSION 3 GRANTED
- 13 May 2026 — SOU EXTENSION 3 FILED
- 13 May 2026 — SOU TEAS EXTENSION RECEIVED
- 06 Nov 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 05 Nov 2025 — SOU EXTENSION 2 GRANTED
- 05 Nov 2025 — SOU EXTENSION 2 FILED
- 05 Nov 2025 — SOU TEAS EXTENSION RECEIVED
- 23 May 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 22 May 2025 — SOU EXTENSION 1 GRANTED
- 22 May 2025 — SOU EXTENSION 1 FILED
- 22 May 2025 — SOU TEAS EXTENSION RECEIVED
- 26 Nov 2024 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 22 Nov 2024 — POST PUBLICATION AMENDMENT - ENTERED
- 18 Nov 2024 — ASSIGNED TO PETITION STAFF